| Followers | 19 |
| Posts | 6586 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Friday, November 18, 2022 2:27:09 AM
WISE WQLF SAYS; The cash on hand from Q2 was at 1.1 Million. The Cash on Paw after Q3 remains at 1.1 Million. No cash burn in Q3 YQU Now Understand YQU Understand Have Mercy Have Partners Have Cantine Merger Have Faith WQLF Ahooooooo
Dr. Joong J Fang Said;
“ Second Quarter 2022 and Recent Financial and Operating Highlights”
“ Total cash balance of $1.1 million at quarter end, compared to $1.4 million at year end;
https://finance.yahoo.com/news/cv-sciences-inc-reports-second-130000549.html
WQLF Says; Have Mercy WQLF Ahooooooo
“ Third Quarter 2022 and Recent Financial and Operating Highlights
“ Total cash balance of $1.1 million at quarter end, compared to $1.4 million at year end;”
https://finance.yahoo.com/news/cv-sciences-inc-reports-third-140000113.html
Dr. Joong J Fang Said;
“ Second Quarter 2022 and Recent Financial and Operating Highlights”
“ Total cash balance of $1.1 million at quarter end, compared to $1.4 million at year end;
https://finance.yahoo.com/news/cv-sciences-inc-reports-second-130000549.html
WQLF Says; Have Mercy WQLF Ahooooooo
“ Third Quarter 2022 and Recent Financial and Operating Highlights
“ Total cash balance of $1.1 million at quarter end, compared to $1.4 million at year end;”
https://finance.yahoo.com/news/cv-sciences-inc-reports-third-140000113.html
Bullish
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
- CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
- CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
